PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-441 Cr | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-441 Cr |
| Mar2024 | ₹-422 Cr |
| Mar2023 | ₹818 Cr |
| Mar2022 | ₹794 Cr |
| Mar2021 | ₹3,977 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-441 Cr | Negative | |
| Mar2024 | ₹-422 Cr | Negative | |
| Mar2023 | ₹818 Cr | 2.97 | |
| Mar2022 | ₹794 Cr | -80.03 | |
| Mar2021 | ₹3,977 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,240.6 Cr | -2.7% | 11.9% | -24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.7% |
11.9% |
-24.4% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses